| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 12/28/2005 | EP1608682A2 Plant haemoglobin |
| 12/28/2005 | EP1608681A2 Rgd-enriched gelatine-like proteins with enhanced cell binding |
| 12/28/2005 | EP1608680A2 Glp-2 derivatives |
| 12/28/2005 | EP1608679A1 Dystrophin-related protein (drop1), a marker for carcinomas |
| 12/28/2005 | EP1608678A1 Process for isolating haemocyanin |
| 12/28/2005 | EP1608677A2 A method for oxygen regulated production of recombinant staphylokinase |
| 12/28/2005 | EP1608676A2 Nontypeable haemophilus influenzae virulence factors |
| 12/28/2005 | EP1608675A2 Immunogenic hiv-1 multi-clade, multivalent constructs and methods of their use |
| 12/28/2005 | EP1608673A2 Peptides and mimetics for reducing symptoms of toxic shock syndrome and septic shock |
| 12/28/2005 | EP1608672A2 Peptides, polypeptides, and proteins of reduced immunogenicity and methods for their production |
| 12/28/2005 | EP1608457A1 Use of recombinant albumin in dialysis after liver failure |
| 12/28/2005 | EP1608414A2 Improved osteoinductive materials |
| 12/28/2005 | EP1608409A2 Peptides selectively lethal to malignant and transformed mammalian cells |
| 12/28/2005 | EP1608404A2 Methods and means to suppress symptons of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (gitr or tnfrsf18) |
| 12/28/2005 | EP1608402A1 Improved vaccines |
| 12/28/2005 | EP1608401A1 Use of alum and a th1 immune response inducing adjuvant for enhancing immune respones |
| 12/28/2005 | EP1608399A2 Ligands for tgf--beta binding proteins and uses thereof |
| 12/28/2005 | EP1608393A2 Ebola peptides and immunogenic compositions containing same |
| 12/28/2005 | EP1608320A2 Novel imidazoline receptor homologs |
| 12/28/2005 | EP1608312A2 Methods for obtaining colonization factors from bacterial strains |
| 12/28/2005 | EP1608308A2 Anti-inflammatory activity from lactic acid bacteria |
| 12/28/2005 | EP1456394A4 Methods of using improved polymerases |
| 12/28/2005 | EP1379539A4 Methods and materials for making and using transgenic dicamba-degrading organisms |
| 12/28/2005 | EP1364029B1 FUSION PROTEIN comprising hirudin and proinsulin or insulin |
| 12/28/2005 | EP1335987B1 Modified vaccinia ankara virus variant |
| 12/28/2005 | EP1315806B1 Method for screening highly active proteases and inhibitors |
| 12/28/2005 | EP1221482B1 Hemopoietin receptor protein, nr12 |
| 12/28/2005 | EP1161561B1 One step sample preparation and detection of nucleic acids in complex biological samples |
| 12/28/2005 | EP1135158B1 Enhanced vaccines based on chimeric immunoglobulin e peptides |
| 12/28/2005 | EP1123114B1 Virus-like particles for the induction of autoantibodies |
| 12/28/2005 | EP1092037B1 Cell culture process for producing glycoproteins |
| 12/28/2005 | EP1085909B1 A complex of alpha-fetoprotein (AFP) and a polyunsaturated fatty acid derivative for the treatment of immune deficiencies |
| 12/28/2005 | EP1078264B1 Tumour markers |
| 12/28/2005 | EP1073683B1 G-csf receptor agonist antibodies and screening method therefor |
| 12/28/2005 | EP1025227B1 Human toll homologues |
| 12/28/2005 | EP1021544B1 Chimeric vaccine against tick-borne encephalitis virus |
| 12/28/2005 | EP0953642B1 Antigenic protein originating in infectious laryngotracheitis virus |
| 12/28/2005 | EP0940467B1 Promoters for swine complement inhibitors |
| 12/28/2005 | EP0925356B1 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines |
| 12/28/2005 | EP0920534B1 Mutations in the diabetes susceptibility genes hepatocyte nuclear factor (hnf) hnf-1alpha, hnf-1beta and hnf-4alpha |
| 12/28/2005 | EP0920448B1 Truncated glial cell line-derived neurotrophic factor |
| 12/28/2005 | EP0879281B1 Methods for transforming dendritic cells and activating t cells |
| 12/28/2005 | EP0859840B1 Biologically active eph family ligands |
| 12/28/2005 | EP0839158B1 Method for purifying thrombopoietin |
| 12/28/2005 | EP0797676B1 Recombinant adenoviral vector and methods of use |
| 12/28/2005 | EP0797589B1 Peptides usable as vectors for the intracellular addressing of active molecules |
| 12/28/2005 | EP0787186B1 Neuronal apoptosis inhibitor protein, gene sequence and mutations causative of spinal muscular atrophy |
| 12/28/2005 | EP0716609B1 Methods and compositions for stimulating and inhibiting tgf-beta activity |
| 12/28/2005 | EP0682529B2 Antibody for the treatment of insulin dependent diabetes |
| 12/28/2005 | EP0672159B1 Homologous sequence targeting in eukaryotic cells |
| 12/28/2005 | EP0662134B1 Polypeptides involved in streptogramin biosynthesis, nucleotide sequences coding for said polypeptides and use thereof |
| 12/28/2005 | EP0652964B1 K. lactis transaldolase gene promoter and use thereof |
| 12/28/2005 | EP0646175B1 Recombinant pseudomonas exotoxin with increased activity |
| 12/28/2005 | EP0642585B1 Activation of oligomerizing receptors by using fused receptor ligands |
| 12/28/2005 | CN1714153A Recombinant protein variants |
| 12/28/2005 | CN1714151A Novel glutamate receptor modulatory proteins and nucleic acid molecules and uses therefor |
| 12/28/2005 | CN1714150A Genetic products differentially expressed in tumors and the use thereof |
| 12/28/2005 | CN1714148A Viral deconstruction through capsid assembly in vitro |
| 12/28/2005 | CN1714116A Modified bio-related substance, process for producing the same, and intermediate |
| 12/28/2005 | CN1714102A T cell receptor display |
| 12/28/2005 | CN1714101A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells. |
| 12/28/2005 | CN1714100A Antigen peptides |
| 12/28/2005 | CN1713921A Live attenuated vaccine against porcine pleuropneumonia |
| 12/28/2005 | CN1713920A Modified transferrin fusion proteins |
| 12/28/2005 | CN1712534A Nucleic acid structure and expression carrier for enhancing recombinant protein production and mass-production of recombinant protein |
| 12/28/2005 | CN1712414A Method for diagnosing and treating baldness from human Rhbd15 gene and its coding product |
| 12/28/2005 | CN1712067A Pharmaceutical preparation of recombinant factor VIII lyophilized without albumin as a stabilizer |
| 12/28/2005 | CN1233830C China bee and hornet hemolysis peptide precursor gene and coded polypeptide and preparing method |
| 12/28/2005 | CN1233820C Bacterial host strains |
| 12/28/2005 | CN1233816C Recombinant yeast strain and IFN alpha-la interferon purifying process |
| 12/28/2005 | CN1233658C Anti endothelial cell element, genes encoding same and pharmaceutical uses thereof |
| 12/28/2005 | CN1233657C Anticoagulation raticide immunogen synthesis method |
| 12/28/2005 | CN1233656C Unsaturated fatty acid modified insulin and preparing method thereof |
| 12/28/2005 | CN1233655C Gene BjCET3 of indian mustard cation output transporting proteins and its protein |
| 12/28/2005 | CN1233417C Peptide P227 analogs, and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes |
| 12/28/2005 | CN1233415C CD26/DPP IV application in preparation of medicine for treating and/or diagnosing disease |
| 12/28/2005 | CN1233230C Method for preserving a hemoglobin blood substitute |
| 12/27/2005 | US6979765 Inbred corn line G6103 |
| 12/27/2005 | US6979763 Hybrid maize plant & seed 38G60 |
| 12/27/2005 | US6979730 Nucleic acids encoding prostate stem cell antigen |
| 12/27/2005 | US6979727 Polypeptide for use in the treatment and prevention of viral diseases |
| 12/27/2005 | US6979726 Immunoconjugates |
| 12/27/2005 | US6979725 Transgenic seed; polypeptides |
| 12/27/2005 | US6979724 Nucleotide sequences coding polypeptide for use in the treatment tumors, nervous system and cardiovascular disorders |
| 12/27/2005 | US6979572 a modified tertiapin peptide containing a stable tertiapin derivative wherein the methionine residue in position 13 of tertiapin is replaced by glutamine. controls insulin secretion, cardiac rhythm, electrical conduction |
| 12/27/2005 | US6979564 Nucleotide squences coding polypeptide for use in the treatment of tumors |
| 12/27/2005 | US6979560 Eschericha bacteria overexpressing the yahn gene for feedback-insensitive amino acid production |
| 12/27/2005 | US6979559 Polyvalent cation-sensing receptor in atlantic salmon |
| 12/27/2005 | US6979558 Polyvalent cation-sensing receptor in Atlantic salmon |
| 12/27/2005 | US6979557 Comprise olignucleotide sequences associated with translation initiation for analyzing the function of polypeptide |
| 12/27/2005 | US6979555 Hyaluronan receptor for endocytosis |
| 12/27/2005 | US6979554 polypeptide has an affinity for a phospholipid selected from a phosphatidylserine, a phosphatidylethanolamine, a phosphatidylinositol, a phosphatidic acid, and a cardiolipin |
| 12/27/2005 | US6979549 Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a CLLD8 protein |
| 12/27/2005 | US6979548 Chemokine receptor obtained from a CDNA library of fetal liver-spleen |
| 12/27/2005 | US6979547 Methods for designing specific ion channel blockers |
| 12/27/2005 | US6979546 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify the same |
| 12/27/2005 | US6979539 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 12/27/2005 | US6979538 Directed evolution of novel binding proteins |
| 12/27/2005 | US6979535 Diagnosing viral infection in mammals; obtain fluid sample, extract nucleotide sequences, incubate with viral probe, detect hybridization, hybridization signal indicates presence of viral sequence |
| 12/27/2005 | US6979451 administering a vaccine to ruminants; antigen from tick cell culture, reducing infection in the ticks that feed on cattle |